Methylphenidate for attention-deficit/hyperactivity disorder in patients with Smith–Magenis syndrome: protocol for a series of N-of-1 trials

BACKGROUND: Smith–Magenis syndrome (SMS) is a rare genetic neurodevelopmental disorder characterized by intellectual disability and severe behavioural and sleep disturbances. Often, patients with SMS are diagnosed with attention-deficit/hyperactivity disorder (ADHD). However, the effectiveness of me...

Descripción completa

Detalles Bibliográficos
Autores principales: Müller, A. R., Zinkstok, J. R., Rommelse, N. N. J., van de Ven, P. M., Roes, K. C. B., Wijburg, F. A., de Rooij-Askes, E., Linders, C., Boot, E., van Eeghen, A. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424817/
https://www.ncbi.nlm.nih.gov/pubmed/34496899
http://dx.doi.org/10.1186/s13023-021-02003-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424817/
https://www.ncbi.nlm.nih.gov/pubmed/34496899
http://dx.doi.org/10.1186/s13023-021-02003-z

Ejemplares similares